Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Lisdexamfetamine in Children and Adolescents with ADHD
NCT01328756Phase 4Completed
- Sponsor
- Takeda
- Start
- Jul 2011
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 4 trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD), sponsored by Takeda. Started Jul 2011; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01328756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01328756.